BNP Paribas Arbitrage SA Has $373,000 Holdings in Phibro Animal Health Corp (PAHC)

BNP Paribas Arbitrage SA grew its stake in Phibro Animal Health Corp (NASDAQ:PAHC) by 69.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,076 shares of the company’s stock after buying an additional 4,143 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Phibro Animal Health were worth $373,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of PAHC. Geode Capital Management LLC increased its position in Phibro Animal Health by 9.9% in the first quarter. Geode Capital Management LLC now owns 162,869 shares of the company’s stock worth $4,576,000 after buying an additional 14,655 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Phibro Animal Health by 12.3% in the first quarter. Dimensional Fund Advisors LP now owns 396,007 shares of the company’s stock worth $11,128,000 after buying an additional 43,260 shares in the last quarter. Renaissance Technologies LLC increased its position in Phibro Animal Health by 269.8% in the first quarter. Renaissance Technologies LLC now owns 51,400 shares of the company’s stock worth $1,444,000 after buying an additional 37,500 shares in the last quarter. State Street Corp increased its position in Phibro Animal Health by 6.1% in the first quarter. State Street Corp now owns 489,093 shares of the company’s stock worth $13,745,000 after buying an additional 28,273 shares in the last quarter. Finally, Bank of Montreal Can increased its position in Phibro Animal Health by 21.3% in the second quarter. Bank of Montreal Can now owns 54,458 shares of the company’s stock worth $2,018,000 after buying an additional 9,572 shares in the last quarter. Institutional investors and hedge funds own 48.42% of the company’s stock.

In related news, insider Dean J. Warras sold 10,000 shares of the stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $35.70, for a total transaction of $357,000.00. Following the completion of the transaction, the insider now directly owns 10,000 shares of the company’s stock, valued at $357,000. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Richard G. Johnson sold 55,529 shares of the stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $36.30, for a total value of $2,015,702.70. Following the transaction, the chief financial officer now directly owns 15,900 shares of the company’s stock, valued at $577,170. The disclosure for this sale can be found here. In the last ninety days, insiders sold 212,125 shares of company stock valued at $7,704,339. Corporate insiders own 51.88% of the company’s stock.

A number of analysts have commented on PAHC shares. Bank of America restated an “underperform” rating and issued a $33.00 price target on shares of Phibro Animal Health in a research report on Wednesday, August 23rd. Zacks Investment Research cut Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Wednesday, November 8th. BidaskClub cut Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 2nd. Piper Jaffray Companies set a $42.00 price objective on Phibro Animal Health and gave the stock a “buy” rating in a research note on Friday, August 25th. Finally, ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $38.25.

Phibro Animal Health Corp (NASDAQ:PAHC) opened at $32.75 on Monday. The firm has a market capitalization of $1,315.99, a PE ratio of 21.41, a PEG ratio of 3.84 and a beta of 1.27. The company has a debt-to-equity ratio of 1.91, a current ratio of 3.26 and a quick ratio of 1.85. Phibro Animal Health Corp has a one year low of $26.10 and a one year high of $40.25.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. The firm had revenue of $193.40 million during the quarter, compared to analyst estimates of $189.89 million. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.36 earnings per share. research analysts forecast that Phibro Animal Health Corp will post 1.57 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date is Tuesday, December 5th. Phibro Animal Health’s dividend payout ratio (DPR) is 23.53%.

ILLEGAL ACTIVITY WARNING: “BNP Paribas Arbitrage SA Has $373,000 Holdings in Phibro Animal Health Corp (PAHC)” was first posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2017/12/11/bnp-paribas-arbitrage-sa-has-373000-holdings-in-phibro-animal-health-corp-pahc.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply